NYSE$SEM
Select Medical Holdings Corporation · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Announced results for the second quarter ended June 30, 2022, and declared a cash dividend.
Select Medical Holdings Corporation reported a 1.3% increase in revenue to $1,584.7 million for the second quarter ended June 30, 2022, compared to $1,564.0 million for the same quarter, prior year. Net income was $66.3 million, compared to $196.2 million for the same quarter, prior year. Earnings per common share was $0.43, compared to $1.22 for the same quarter, prior year.
- Revenue increased 1.3% to $1,584.7 million compared to the same quarter last year.
- Net income decreased to $66.3 million compared to $196.2 million for the same quarter, prior year.
- Earnings per common share decreased to $0.43 compared to $1.22 for the same quarter, prior year.
- Select Medical reaffirms its 2022 business outlook for revenue, expecting consolidated revenue to be in the range of $6.25 billion to $6.40 billion.
Headline financials
Revenue & EPS history
Select Medical · Revenue · Quarterly
$1.58B
Revenue by segment
Select Medical · $1.06B total across 3 segments · Q2 2022
- Critical Illness Recovery$546M+0.3%51.4%
- Outpatient Rehabilitation$287M+2.5%27.1%
- Rehabilitation Hospital$229M+7.6%21.6%
Forward guidance
Select Medical reaffirms its 2022 business outlook for revenue and its previously issued three-year compound annual growth rate target for revenue only.
Tailwinds
- Consolidated revenue is expected to be in the range of $6.25 billion to $6.40 billion for the full year of 2022.
- Three-year compound annual growth rate target for revenue is expected to be in the range of 4% to 6% for 2021 through 2023.
Headwinds
- The company intends to address its business outlook and target compound annual growth rates for Adjusted EBITDA and earnings per common share when the labor climate stabilizes.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
-0.3%
Avg return
Earnings day
+0.1%
Avg return
5 days after
+0.5%
Avg return
30 days after
49%
32 / 65 earnings
Positive
+18.8%
Q3 2018
Best reaction
-22.2%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +0.1% | +0.7% | |
| Q4 2025 | -6.5% | -7.3% | +1.1% | |
| Q3 2025 | -5.8% | -5.1% | +9.1% | |
| Q1 2025 | -22.2% | -17.7% | -16.2% | |
| Q4 2024 | -7.2% | -2.9% | -13.1% | |
| Q3 2024 | +9.4% | +13.3% | +19.3% | |
| Q2 2024 | -14.0% | -17.2% | -9.3% | |
| Q1 2024 | +12.3% | +17.0% | +23.5% | |
| Q4 2023 | +6.7% | +4.6% | +7.7% | |
| Q3 2023 | -1.2% | -2.7% | +3.9% | |
| Q2 2023 | -1.3% | -2.5% | -4.3% | |
| Q1 2023 | +4.8% | -0.8% | -2.8% | |
| Q4 2022 | -7.8% | -9.1% | -17.6% | |
| Q3 2022 | -6.5% | -10.9% | +0.9% | |
| Q2 2022 | -4.1% | -11.1% | -14.7% | |
| Q1 2022 | +0.9% | -4.2% | +10.6% | |
| Q4 2021 | +1.1% | +2.2% | +3.5% | |
| Q3 2021 | +2.4% | -0.9% | -18.4% | |
| Q2 2021 | -3.3% | -6.9% | -7.7% | |
| Q1 2021 | -2.5% | -3.1% | +4.9% | |
| Q4 2020 | +10.5% | +16.9% | +20.5% | |
| Q3 2020 | -1.7% | +8.5% | +15.4% | |
| Q2 2020 | +13.1% | +14.7% | +21.2% | |
| Q1 2020 | -15.3% | -12.9% | -6.3% | |
| Q4 2019 | +8.9% | -0.1% | -55.6% | |
| Q3 2019 | +5.7% | +10.6% | +22.9% | |
| Q2 2019 | -5.8% | -5.8% | -3.1% | |
| Q1 2019 | +1.7% | +3.0% | -1.3% | |
| Q4 2018 | +0.1% | -4.8% | -10.1% | |
| Q3 2018 | +18.8% | +21.2% | +16.9% | |
| Q2 2018 | -5.0% | -7.5% | -6.6% | |
| Q1 2018 | -4.4% | -3.5% | -2.9% | |
| Q4 2017 | +11.2% | +11.4% | +7.8% | |
| Q3 2017 | -7.8% | -9.4% | -6.5% | |
| Q2 2017 | +8.6% | +12.7% | +18.7% | |
| Q1 2017 | +5.9% | +1.1% | +3.7% | |
| Q4 2016 | +9.6% | +11.6% | -3.1% | |
| Q3 2016 | -8.2% | -6.1% | -1.2% | |
| Q2 2016 | +10.6% | +6.3% | +9.3% | |
| Q1 2016 | -4.5% | — | — | |
| Q4 2015 | +10.9% | — | — | |
| Q3 2015 | +5.0% | — | — | |
| Q2 2015 | +0.1% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | -5.2% | — | — | |
| Q3 2014 | +11.3% | — | — | |
| Q2 2014 | -12.4% | — | — | |
| Q1 2014 | +0.5% | — | — | |
| Q4 2013 | +1.7% | — | — | |
| Q3 2013 | +1.1% | — | — | |
| Q2 2013 | +1.3% | — | — | |
| Q1 2013 | -2.5% | — | — | |
| Q4 2012 | +4.0% | — | — | |
| Q3 2012 | +10.0% | — | — | |
| Q2 2012 | +9.1% | — | — | |
| Q1 2011 | -3.2% | — | — | |
| Q1 2012 | +1.1% | — | — | |
| Q4 2009 | -0.4% | — | — | |
| Q4 2011 | -0.4% | — | — | |
| Q3 2010 | -2.4% | — | — | |
| Q3 2011 | -2.4% | — | — | |
| Q4 2010 | -15.8% | — | — | |
| Q2 2010 | -15.8% | — | — | |
| Q2 2011 | -15.8% | — | — | |
| Q1 2010 | -7.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro